Aims and Scope of Current Pharmaceutical Design
Current Pharmaceutical Design is a peer-reviewed medical journal which covers issues related to pharmacology and medicinal chemistry. Each issue is devoted to a single major therapeutic area. For each issue, an executive editor is chosen who is an acknowledged authority in that field. Less
Key Metrics
CiteScore 

5.8
H-Index 

176
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

0.73
Recommended pre-submission checks
Powered by 

Topics Covered on Current Pharmaceutical Design
Current Pharmaceutical Design Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Design ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Pharmaceutical Design
Formulation, Characterization, and Preliminary In Vitro Evaluation of Letrozole Incorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells.
- 25 Jul 2026
- Current pharmaceutical design
Modern Trends in the Development of Natural and Synthetic Anti-Tuberculosis Drugs.
- 25 Jul 2026
- Current pharmaceutical design
Nutritional Adjuvants in Diabetes: Biotin and Chromium Picolinate as Emerging Therapeutic Agents.
- 25 Jul 2026
- Current pharmaceutical design
Integrated Network Pharmacology and Experimental Study: Bioactive Compounds and Mechanisms of XuanTong BuLuo Decoction in Treating Diabetic Cardiomyopathy.
- 24 Jul 2026
- Current pharmaceutical design
Harnessing Natural Bioactive Compounds for Ocular Health: A Comprehensive Review.
- 23 Jul 2026
- Current pharmaceutical design
A Comprehensive Review of Phosphodiesterases 4 (PDE4) Inhibitors in Clinical Trials.
- 23 Jul 2026
- Current pharmaceutical design
Formulation, Characterization, and Preliminary In Vitro Evaluation of Letrozole Incorporated Eudragit® RS 100 Nanoparticles Using HepG2 Cells.
- 25 Jul 2026
- Current pharmaceutical design
Modern Trends in the Development of Natural and Synthetic Anti-Tuberculosis Drugs.
- 25 Jul 2026
- Current pharmaceutical design
Nutritional Adjuvants in Diabetes: Biotin and Chromium Picolinate as Emerging Therapeutic Agents.
- 25 Jul 2026
- Current pharmaceutical design
Integrated Network Pharmacology and Experimental Study: Bioactive Compounds and Mechanisms of XuanTong BuLuo Decoction in Treating Diabetic Cardiomyopathy.
- 24 Jul 2026
- Current pharmaceutical design
Harnessing Natural Bioactive Compounds for Ocular Health: A Comprehensive Review.
- 23 Jul 2026
- Current pharmaceutical design
A Comprehensive Review of Phosphodiesterases 4 (PDE4) Inhibitors in Clinical Trials.
- 23 Jul 2026
- Current pharmaceutical design
FAQs on Current Pharmaceutical Design
How long has Current Pharmaceutical Design been actively publishing? 
What is the publishing frequency of Current Pharmaceutical Design? 
How many articles did Current Pharmaceutical Design publish last year? 
What is the eISSN & pISSN for Current Pharmaceutical Design? 
What is Citescore for Current Pharmaceutical Design? 
What is the H Index for Current Pharmaceutical Design ? 
What is SNIP score for Current Pharmaceutical Design? 
What is the SJR for Current Pharmaceutical Design? 
Who is the publisher of Current Pharmaceutical Design? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary